#dps group

[prismpub]

DPS Group and TRIA congratulate Moderna on ISPE 2019 Facility of the Future Category Award

DPS Group and TRIA congratulate Moderna on ISPE 2019 Facility of the Future Category Award

Moderna’s cGMP clinical development manufacturing facility takes category win in the 2019 ISPE Facility of the Year Award Program

BOSTON, April 2, 2019 /PRNewswire/ — DPS Group, a privately-owned, global consulting, engineering, procurement, construction management and validation firm serving high-tech process industries, and design affiliate TRIA, a partner-led architecture firm with a focus on…

View On WordPress

[prismpub]

DPS Group to design two cGMP manufacturing facilities for Brammer Bio

DPS Group to design two cGMP manufacturing facilities for Brammer Bio

Firm brings expertise in designing flexible clinical and commercial suites for gene and cell therapy sector

 BOSTON – Jan. 9, 2019 – DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, announced today that it has been selected to design two cGMP manufacturing facilities for Brammer Bio, an…

View On WordPress

[prismpub]

DPS Group and Hodess Cleanroom Construction Complete Proprietary Cell Therapy Manufacturing Facility for Mustang Bio

DPS Group and Hodess Cleanroom Construction Complete Proprietary Cell Therapy Manufacturing Facility for Mustang Bio

Design/build team brings expertise in cGMP and cleanroom design and construction to new CAR T and gene therapy development facility

BOSTON – November 28, 2018  – DPS Group, a privately-owned, global engineering company, and Hodess Cleanroom Construction, a comprehensive cleanroom construction company, today announced that they have completed a proprietary cell therapy manufacturing facility for M…

View On WordPress

[prismpub]

DPS Group and TRIA Celebrate Opening of State-of-the-Art cGMP mRNA Clinical Manufacturing Facility for Moderna Therapeutics

DPS Group and TRIA Celebrate Opening of State-of-the-Art cGMP mRNA Clinical Manufacturing Facility for Moderna Therapeutics

Project team designs and delivers an ambitious, integrated, end-to-end process facility for the research and manufacture of Moderna’s pipeline of mRNA-based medicines

BOSTON – July 20, 2018 – DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, and design affiliate TRIA, a partner-led architecture…

View On WordPress